| Literature DB >> 34515152 |
Marlies Ostermann1, Emma Karsten2, Nuttha Lumlertgul1,3,4.
Abstract
New biomarkers for acute kidney injury (AKI) have improved our understanding of the etiology and pathogenesis of AKI. Depending on their origin, function, and kinetic profile, biomarkers have a role in screening, diagnosis, prognostication, and monitoring of AKI. This offers opportunities to improve the management of AKI, but concerns and limitations remain. In this review, we summarize the current role of new AKI biomarkers in the management of AKI and outline some of the ongoing limitations and challenges.Entities:
Keywords: Acute kidney injury; Biomarkers
Mesh:
Substances:
Year: 2021 PMID: 34515152 PMCID: PMC9216309 DOI: 10.1159/000518365
Source DB: PubMed Journal: Nephron ISSN: 1660-8151 Impact factor: 3.457